Evaluate the Efficacy and Safety of Anti‐Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta‐Analysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jcb.25936PMID 28214290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.

  2016cited by this paper
• Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial

  2016cited by this paper
• Adjunctive pregabalin vs gabapentin for focal seizures

  2016cited by this paper
• Adjunctive perampanel in adolescents with inadequately controlled partial‐onset seizures: A randomized study evaluating behavior, efficacy, and safety

  2016cited by this paper
• Epilepsy: new advances.

  2015cited by this paper
• Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trials.

  2015cited by this paper
• Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study.

  2015cited by this paper
• Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy

  2015cited by this paper
• Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial‐onset seizures

  2015cited by this paper
• Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.

  2015cited by this paper
• A randomized, double‐blind, placebo‐controlled, multicenter, parallel‐group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial‐onset seizures

  2015cited by this paper
• Comparative Efficacy of Zonisamide and Pregabalin as an Adjunctive Therapy in Children with Refractory Epilepsy

  2015cited by this paper
• Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy

  2015cited by this paper
• Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: A phase 1, randomized controlled study

  2014cited by this paper
• The hidden genetics of epilepsy—a clinically important new paradigm

  2014cited by this paper
• Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study

  2014cited by this paper
• Zonisamide: A Review of Its Use as Adjunctive Therapy in the Management of Partial Seizures in Pediatric Patients Aged ≥6 Years

  2014cited by this paper
• Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double‐blind, randomized, placebo‐controlled trial

  2014cited by this paper
• : A practical clinical definition of epilepsy

  2014cited by this paper
• Prevention of generalized tonic–clonic seizures in refractory focal epilepsy: A meta‐analysis

  2014cited by this paper
• The Efficacy of Leviteracetam versus Carbamazepine for Epilepsy: A Meta-Analysis

  2014cited by this paper
• Adjunctive use of controlled‐release pregabalin in adults with treatment‐resistant partial seizures: A double‐blind, randomized, placebo‐controlled trial

  2014cited by this paper
• Adjunctive zonisamide therapy in the long‐term treatment of children with partial epilepsy: Results of an open‐label extension study of a phase III, randomized, double‐blind, placebo‐controlled trial

  2014cited by this paper
• Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.

  2014cited by this paper
• Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double‐blind, noninferiority trial

  2014cited by this paper
• Efficacy of lacosamide by focal seizure subtype.

  2014cited by this paper
• Comparative efficacy and tolerability of anti‐epileptic drugs for refractory focal epilepsy: systematic review and network meta‐analysis reveals the need for long term comparator trials

  2013cited by this paper
• Excitotoxicity: bridge to various triggers in neurodegenerative disorders.

  2013cited by this paper
• Evaluation of adjunctive perampanel in patients with refractory partial‐onset seizures: Results of randomized global phase III study 305

  2013cited by this paper
• Correlation of EEG, CT, and MRI Brain with Neurological Outcome at 12 Months in Term Newborns with Hypoxic Ischemic Encephalopathy

  2013influential reference
• Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial

  2013cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration

  2013cited by this paper
• Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance

  2012cited by this paper
• Adjunctive perampanel for refractory partial-onset seizures

  2012cited by this paper
• Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

  2012cited by this paper
• Randomized phase III study 306

  2012cited by this paper
• Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy

  2011cited by this paper
• Efficacy and Safety of Adjunctive Zonisamide in Adult Patients with Refractory Partial-Onset Epilepsy

  2011cited by this paper
• Topiramate as an Adjunctive Treatment for Refractory Partial Epilepsy in the Elderly

  2011cited by this paper
• Incidence of epilepsy

  2011cited by this paper
• A randomized, double‐blind, placebo‐controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial‐onset seizures

  2011cited by this paper
• A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures.

  2010cited by this paper
• A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.

  2010cited by this paper
• Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trial

  2010cited by this paper
• Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.

  2010cited by this paper
• A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo‐controlled trials

  2010cited by this paper
• Pregabalin add‐on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: A double‐blind, randomized, placebo‐controlled, multicenter trial

  2009cited by this paper
• Adjunctive levetiracetam in infants and young children with refractory partial‐onset seizures

  2009cited by this paper
• Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo‐controlled trial

  2009cited by this paper
• Neurocognitive effects of adjunctive levetiracetam in children with partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, noninferiority trial

  2009cited by this paper
• Adjunctive lacosamide for partial‐onset seizures: Efficacy and safety results from a randomized controlled trial

  2009cited by this paper
• Multicenter double‐blind, randomized, placebo‐controlled trial of levetiracetam as add‐on therapy in Chinese patients with refractory partial‐onset seizures

  2009cited by this paper
• Efficacy and Safety of Levetiracetam (3,000 mg/Day) as an Adjunctive Therapy in Chinese Patients with Refractory Partial Seizures

  2009cited by this paper
• Once‐daily extended‐release levetiracetam as adjunctive treatment of partial‐onset seizures in patients with epilepsy: A double‐blind, randomized, placebo‐controlled trial

  2009cited by this paper
• Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures

  2009cited by this paper
• Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, parallel‐group phase III study

  2009cited by this paper
• Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.

  2008cited by this paper
• Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

  2008cited by this paper
• Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures

  2008cited by this paper
• Lamotrigine extended-release as adjunctive therapy for partial seizures

  2007cited by this paper
• Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures

  2007cited by this paper
• Eslicarbazepine Acetate: A Double‐blind, Add‐on, Placebo‐controlled Exploratory Trial in Adult Patients with Partial‐onset Seizures

  2007cited by this paper
• Efficacy and Safety of Oral Lacosamide as Adjunctive Therapy in Adults with Partial‐Onset Seizures

  2007cited by this paper
• Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures

  2006cited by this paper
• Treatment of partial seizures with gabapentin: Double‐blind, placebo‐controlled, parallel‐group study *

  2006cited by this paper
• Efficacy and Safety of Levetiracetam (up to 2000 mg/day) in Taiwanese Patients with Refractory Partial Seizures: A Multicenter, Randomized, Double‐blind, Placebo‐controlled Study

  2006cited by this paper
• A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: Impact on seizures, severity, and quality of life

  2005cited by this paper
• Medical aspects of disability : a handbook for the rehabilitation professional

  2005cited by this paper
• Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures

  2005cited by this paper
• Pregabalin Add‐on Treatment in Patients with Partial Seizures: A Novel Evaluation of Flexible‐dose and Fixed‐dose Treatment in a Double‐blind, Placebo‐controlled Study

  2005cited by this paper
• Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy

  2005cited by this paper
• Dose‐dependent Safety and Efficacy of Zonisamide: A Randomized, Double‐blind, Placebo‐controlled Study in Patients with Refractory Partial Seizures

  2005cited by this paper
• Randomized, Controlled Clinical Trial of Zonisamide as Adjunctive Treatment for Refractory Partial Seizures

  2004cited by this paper
• Pregabalin Add‐on Treatment: A Randomized, Double‐blind, Placebo‐controlled, Dose–Response Study in Adults with Partial Seizures

  2004cited by this paper
• Zonisamide clinical trials: European experience.

  2004cited by this paper
• Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

  2003cited by this paper
• Low‐dose topiramate in adults with treatment‐resistant partial‐onset seizures

  2002cited by this paper
• A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy.

  2001cited by this paper
• Early identification of refractory epilepsy.

  2000cited by this paper
• Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group.

  2000cited by this paper
• A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

  2000cited by this paper
• Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy

  2000cited by this paper
• A Double‐Blind, Placebo‐Controlled Study of Topiramate in Adult Patients with Refractory Partial Epilepsy

  2000cited by this paper
• Levetiracetam for partial seizures

  2000cited by this paper
• Multicenter Double‐Blind, Randomized, Placebo‐Controlled Trial of Levetiracetam as Add‐On Therapy in Patients with Refractory Partial Seizures

  2000cited by this paper
• Efficacy and Tolerability of Levetiracetam 3000 mg/d in Patients with Refractory Partial Seizures: A Multicenter, Double‐Blind, Responder‐Selected Study Evaluating Monotherapy

  2000cited by this paper
• Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group.

  2000cited by this paper
• Gabapentin Versus Vigabatrin as First Add‐On for Patients with Partial Seizures That Failed to Respond to Monotherapy: A Randomized, Double‐Blind, Dose Titration Study

  2000cited by this paper
• A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.

  1999cited by this paper
• Topiramate in Medically Intractable Partial Epilepsies: Double‐Blind Placebo‐Controlled Randomized Parallel Group Trial

  1999cited by this paper
• A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children

  1999cited by this paper
• Gabapentin as Add‐On Therapy in Children with Refractory Partial Seizures: A 12‐Week, Multicentre, Double‐Blind, Placebo‐Controlled Study

  1999cited by this paper
• A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.

  1999cited by this paper
• A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children

  1999cited by this paper
• Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

  1998cited by this paper
• Clinical Efficacy of Topiramate as Add‐On Therapy in Refractory Partial Epilepsy: The European Experience

  1997cited by this paper
• A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures

  1996cited by this paper
• Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.

  1996cited by this paper

• Effectiveness and safety of single anti-seizure medication as adjunctive therapy for drug-resistant focal epilepsy based on network meta-analysis

  2025cites this paper
• Localizing epileptic focus and assessing electrical stimulus effects on epilepsy in rats using stretchable micro electrocorticogram electrodes

  2022cites this paper
• Rufinamide, a Triazole-Derived Antiepileptic Drug, Stimulates Ca2+-Activated K+ Currents While Inhibiting Voltage-Gated Na+ Currents

  2022cites this paper
• Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis

  2022cites this paper
• Comparative efficacy of anti-epileptic drugs for neonatal seizures: A network meta-analysis.

  2021cites this paper
• Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications

  2021cites this paper
• A meta-analysis: efficacy and safety of anti-epileptic drugs prescribed in Korea as monotherapy and adjunctive treatment for patients with focal epilepsy

  2021cites this paper
• Drugs for patients with epilepsy and excessive daytime sleepiness.

  2021cites this paper
• Anticonvulsant Agents: Gabapentin and Pregabalin

  2020cites this paper
• Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice.

  2020cites this paper
• Targeting gap junction in epilepsy: Perspectives and challenges.

  2019cites this paper
• levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.

  2018cites this paper
• Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

  2018cites this paper
• Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.

  2017cites this paper